Targeting TP53 pathologic variants for cancer immunotherapy using a self-replicating mRNA vaccine strategy. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not ...
Selective reductive conversion of CO 2 to CH 2-bridged compounds by using a Fe-functionalized graphene oxide-based catalyst Fig. 4: Schematic representation of the conceptual continuum spanning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results